Clinical Trial Update: A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers [Phase 1]

View source ↗

Summary

A Phase I trial of the radiopharmaceutical [177Lu]Lu-EVS459 in ovarian and lung cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• [177Lu]Lu-EVS459

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ovarian Cancer, Lung Cancer | Phase 1 | Status: TERMINATED